In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...
Please provide your email address to receive an email when new articles are posted on . GLP-1s show benefit in patients with HF, regardless of obesity. GLP-1s raise heart rate, which is linked to ...
Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume if the medication was not held prior to upper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results